1. Home
  2. CHSCL vs VANI Comparison

CHSCL vs VANI Comparison

Compare CHSCL & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CHS Inc

CHSCL

CHS Inc

HOLD

Current Price

$25.30

Market Cap

0.0

Sector

Industrials

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.25

Market Cap

81.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHSCL
VANI
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
81.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CHSCL
VANI
Price
$25.30
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
N/A
192.4K
Earning Date
N/A
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$0.91
52 Week High
N/A
$1.92

Technical Indicators

Market Signals
Indicator
CHSCL
VANI
Relative Strength Index (RSI) 33.14 37.84
Support Level $25.26 $1.36
Resistance Level $25.39 $1.46
Average True Range (ATR) 0.08 0.09
MACD -0.03 -0.01
Stochastic Oscillator 12.61 3.23

Price Performance

Historical Comparison
CHSCL
VANI

About CHSCL CHS Inc

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Share on Social Networks: